Viemed Healthcare (VMD) Net Income towards Common Stockholders (2018 - 2026)

Viemed Healthcare (VMD) has 9 years of Net Income towards Common Stockholders data on file, last reported at $2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders changed 0.11% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $15.4 million (up 22.87% YoY), and the FY2025 full-year result was $15.4 million, up 34.77% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at $2.7 million, down from $5.8 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $5.8 million in Q4 2025 and bottomed at $967000.0 in Q2 2022.
• The 5-year median for Net Income towards Common Stockholders is $2.7 million (2025), against an average of $2.7 million.
• The widest annual swing landed in 2022, when Net Income towards Common Stockholders tumbled 41.03%; it then surged 176.68% in 2023.
• A 5-year view of Net Income towards Common Stockholders shows it stood at $2.4 million in 2022, then jumped by 42.62% to $3.5 million in 2023, then advanced by 27.24% to $4.4 million in 2024, then jumped by 31.46% to $5.8 million in 2025, then sank by 53.35% to $2.7 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at $2.7 million (Q1 2026), $5.8 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.

Peer Comparison